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Abstract
Tissue engineering of the annulus fibrosus (AF) is currently being investigated as a treatment for
intervertebral disc degeneration, a condition frequently associated with low back pain. The objective of this work was to use 3D printing to generate a novel scaffold for AF repair that mimics the
structural and biomechanical properties of the native tissue. Multi-layer scaffolds were fabricated
by depositing polycaprolactone struts in opposing angular orientations, replicating the angle-ply
arrangement of the native AF tissue. Scaffolds were printed with varied strut diameter and spacing.
The constructs were characterized morphologically and by static and dynamic mechanical analyses. Scaffold surfaces were etched with unidirectional grooves and the influence on bovine AF cell
metabolic activity, alignment, morphology and protein expression was studied in vitro. Overall, the
axial compressive and circumferential tensile properties of the scaffolds were found to be in a similar range to the native AF tissue. Confocal microscopy images indicated that cells were able to attach and spread on the smooth polycaprolactone scaffolds, but the surface texture induced cellular
alignment and proliferation. Furthermore, immunofluorescence analysis demonstrated the aligned
deposition of collagen type I, aggrecan and the AF-specific protein marker tenomodulin on the
etched scaffolds. Overall, results demonstrated the potential for using the scaffolds as a template
for AF regeneration.
Keywords: surface modification; scaffolds; materials structure; 3D printing

Introduction
In the USA, reports have shown that low back pain (LBP) affects between 70 and 85% of the population at some point during their lifetime [1]. LBP is frequently associated with degenerated and or
injured intervertebral disc (IVD) [2]. The IVD is composed of three
basic structures: a central nucleus pulposus (NP), a peripheral annulus fibrosus (AF) and two layers of cartilage covering the top and
bottom called cartilage endplates [3]. Changes in the matrix composition of the IVD are associated with LBP [2]. Specifically, disc degeneration can result from damage to or dehydration of the NP,
which reduces its hydrostatic pressure on the internal surface of the
AF. This causes abnormal compressive stresses on the AF, causing
tears, cracks and fissures after repeated loads. Back pain can develop

as a result of NP tissue migrating through the AF, called a herniation, and impinging on nerve roots [4, 5]. Currently, disc degeneration may be treated pharmacologically, with physical therapy, or
surgical intervention. However, these treatments do not address the
underlying degenerative process, so recurrent symptoms and reoperation is common [6–8].
Given these drawbacks, biologic-based therapies, such as tissue
engineering, are currently being investigated for repair of the damaged AF to prevent recurrent herniation. However, the development
of such strategies is a significant challenge due to the complex hierarchical structure and heterogeneity of the tissue. The AF is a layered structure composed of concentric sheets of Collagen I and II,
called lamellae (9). Each adjacent lamella comprised collagen fibers
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oriented in angles from 645 in the inner AF to 630 in the outer
AF, gradually decreasing in angle in a linear fashion [9]. The concentric layers form an angle-ply laminate structure [10, 11]. Attempts
to repair the AF in pre-clinical studies have been met with moderate
success and are summarized in a recent review [12]. Fuller et al. [13]
studied repair of an AF lesion site in an ovine model using an acellular collagen sponge soaked with hyaluronan oligosaccharides.
Remodeling was only detected in the outer AF after 6 months.
Hegewald et al. [14] studied AF repair in an ovine model using a textile polyglycolic acid/polyvinylidene fluoride acellular implant.
Directional matrix was deposited throughout the AF defect at
12 weeks, but in provocative pressure testing, no statistical differences were found between repaired and injured groups. In 2003, Sato
et al. [15] described implantation of allografted AF cells seeded in
an atelocollagen honeycomb-shaped scaffold. After 12 weeks,
hyaline-like cartilage tissue was produced in the AF defect, but the
organization did not resemble that of native AF tissue.
In vitro, researchers have made progress in developing scaffolds
that replicate the fibrous nature of the AF using electrospinning of
polycaprolactone (PCL) [10, 11, 16–18]. Consistent among these
studies is the result that oriented alignment of the fibers results in
better retention of AF phenotype and the aligned deposition of tissue
[11, 19, 20]. Despite progress in the use of electrospinning for AF repair, the method produces close-packed fibers, which may lead to
low pore interconnectivity. Furthermore, although electrospinning
scaffolds can be layered [16], it is difficult to generate porous, 3D
structures, limiting area for cell migration into the material and the
deposition of matrix [11, 17].
Interestingly, 3D printing technologies have not been extensively
researched for fabrication of IVD scaffolds. However, 3D printing
offers great potential for the attainment of angle-ply geometry and
direct printing of various cell types, scaffold materials and biomolecules [21]. Rosenzweig et al. [22] printed mesh structures of acrylonitrile butadiene and polylactic acid. Proliferation and extracellular
matrix (ECM) deposition by NP cells on the scaffolds was demonstrated. Alternatively, resin-based porous scaffolds were printed out
of poly(trimethylene carbonate) [23]. The aligned deposition of collagen by human adipose-derived mesenchymal stem cells (MSCs)
was shown within the scaffold pores. In another study, polyurethane
was printed in concentric rings replicating the lamellar structure of
the AF. The materials were shown to be biocompatible with bovine
IVD cells, but ECM formation was not evaluated [24].
In this work, we used 3D printing to advance AF tissue regeneration by generating a scaffold with angle-ply architecture, requisite
mechanical properties and uniform cell attachment. Addressing
these points, we printed laminar constructs comprised PCL struts
oriented at alternating angles of 630 . The first objective of our
work was based on a 2 2 factorial design to vary scaffold architecture. The diameter of the PCL struts and spacing between the struts
were varied in order to engineer a construct with suitable morphological and mechanical properties for AF repair. To this end, the
scaffolds were assessed by scanning electron microscopy (SEM) and
by static and dynamic mechanical analyses (DMA). The second objective of our work focused on the isolation and culture of bovine
AF cells on the laminar construct. A unidirectional surface texture
was introduced onto the PCL constructs, and the effects on seeded
bovine AF cell metabolic activity, alignment, morphology and protein expression was studied over 21 days in vitro. The results
obtained from this investigation will provide a foundation for further studies on the use of 3D printing and develop scaffolds that can
induce functional assembly of ECM mimicking the native AF.
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(a)
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(b)

Figure 1. Top view (a) and side view (b) of the PCL scaffold mimicking the angle-ply structure of the AF. (c) Factorial study designed to investigate the
properties of the PCL scaffolds

Materials and methods
Materials
PCL (Mn ¼ 72, 918 Da) filament with a 1.75-mm diameter was
purchased from Tipeye (part no. OD3DLINE-US-6PCL05).
Dulbecco’s phosphate buffered saline (PBS), fetal bovine serum
(FBS) and trypsin–ethylenediaminetetraacetic were purchased
from VWR Life Science. High glucose Dulbecco’s minimum essential medium (DMEM), GlutaMAXTM, Pyruvate Supplement and
Antibiotic-Antimycotic 100 were purchased from GibcoTM.
Triton X-100 and Tris buffered saline (TBS, 10, pH 7.4) were
purchased from Fisher Scientific. Ascorbic acid, Type I collagen
from calf skin, 1-ethyl-(3-3-dimethylaminopropyl) carbodiimide
hydrochloride (EDC), and Collagenase P were purchased from
Sigma Aldrich.

Scaffold fabrication
Models (Fig. 1a) were made as standard tessellation language files
using the cloud-based 3D CAD system OnShape. Constructs were
printed on a Robo 3D R1 (Robo, San Diego, CA, USA). PCL was
dispensed through a 400-lm nozzle size, maintained at 130 C at a
deposition rate of 340 mm/min onto a bed maintained at 40 C.
Scaffolds were drawn with two different strut thicknesses (700 and
1300 lm) and two different strut spaces (1300 and 2000 lm)
(Fig. 1b). The constructs were fabricated as rectangular shaped
(24 L 48 mm W) and comprised four total layers, each with thickness set to 1000 lm. The PCL struts in each layer were oriented at
angle theta (h) of 630 . After printing, smaller rectangular samples
were excised for porosity and SEM analysis (9 L 6 mm W), DMA
(45 L9 mm W), tensile testing (17 L5 mm W), compressive testing
(8 L5 mm W) or cell culture (5 L3 mm W). For cell culture, a
group of PCL scaffolds were manually surface-modified with unidirectional grooves using 30 lm grit sandpaper and designated as the
‘etched’ group. PCL scaffolds that did not receive a surface treatment and used for cell culture are designated as the ‘smooth’ group.

Porosity measurement
The porosity (P) was experimentally measured by analyzing the
mass and volume of the samples (n ¼ 5), as (25): where qPCL is the
density of solid PCL after printing, measured experimentally to be
1.13 g/cm3.


MS 1
P¼1
;
(1)

VS qPCL
where MS is the scaffold’s mass, VS is the scaffold’s volume and qPCL
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is the density of solid PCL after printing, measured experimentally
to be 1.13 g/cm3.

Scanning electron microscopy
Smooth and etched scaffold samples were sputtered in gold and
characterized by SEM (Phenom Pure, Phenom-World B.V., The
Netherlands). Topographical feature size was quantified by ImageJ
(NIH, Bethesda, MD, USA).

Mechanical characterization
Static mechanical analysis
Samples were loaded onto an EZ-X Series Universal
Electromechanical test frame (Shimadzu, Kyoto, Japan), subjected
to a pre-load of 0.1 N, and stretched or compressed at room temperature at a rate of 0.2% strain/s. For tensile testing, samples (n ¼ 5)
were clamped with serrated grips and stretched in the circumferential tensile direction. For compressive testing, samples (n ¼ 5) were
loaded unconfined in the axial direction. The compressive and tensile moduli were computed by converting load–displacement data to
stress–strain and measuring the slope of the chord drawn between 5
and 15% strain.
Dynamic mechanical analysis
Samples (n ¼ 3) were loaded onto a Q800 DMA (TA Instruments,
New Castle, DE, USA) for single cantilever analysis using a 1 Hz frequency 7.5 lm amplitude and 0.35 Poisson’s ratio. Samples were
equilibrated at 80 C for 10 min then ramped to 40 C at a rate of
2 C/min. Values of storage modulus (E0 ), loss modulus (E00 ), mechanical loss (tan d) and complex modulus (E*) were recorded over
the temperature range studied. The glass transition temperature (Tg)
was determined as the temperature at which tan d peaked. The molecular weight between entanglements (Me) was calculated from the
rubbery storage modulus above Tg as:
E0 ¼

3 q R T
Me

(2)

where q is the density of PCL, R is the universal gas constant, T
is the temperature, in this case 25 C, and E0 is the storage modulus
at 25 C.

Cell culture studies
Collagen coating
To improve the biological properties of synthetic PCL [26–28], the
smooth and etched scaffolds were coated in collagen. Excised scaffolds for cell culture were soaked in 0.5% (w/v) solution of Type I
collagen in 0.05 M acetic acid at room temperature [26] for 1 h.
Subsequently, the scaffolds were allowed to dry in air for 24 h, followed by immersion in a 50 mM EDC solution in 95% ethanol for
24 h at room temperature, to induce crosslinking of the collagen
layer [27, 28]. Post-crosslinking, the scaffolds were washed five
times in deionized water and lyophilized. Immediately prior to cell
culture, scaffolds were sterilized by immersion in 70% ethanol.
Cell isolation
Caudal IVDs were aseptically excised from bovine tails within 24 h
of death. Cartilage endplate were removed with a razor blade and
the outer AF was dissected with a 1.5 mm biopsy punch. The tissue
samples were placed in culture medium, composed of DMEM supplemented with 10% FBS, 100 IU/ml penicillin–100 lg/ml

streptomycin, 0.25 lg/ml amphotericin B and 50 mg/ml ascorbic
acid, supplemented with 0.5% (w/v) collagenase P overnight at
37 C. The resulting suspension was passed through a 100 mm cell
strainer, pelleted, washed in sterile PBS and re-suspended in the
same medium without the addition of collagenase P. Cellular viability and number were verified and counted using the trypan blue exclusion method. For expansion, the bovine AF cells were seeded in
monolayers at a density of 2 104 cells/cm2 and passaged up to P3
to obtain sufficient cell numbers for the experiments.
For cell seeding, 400 ll of AF cell suspension (100 000 cells/ml)
was applied over each scaffold. Cells were allowed to attach for 48 h
under static culture conditions. At this point, samples were aseptically transferred to new wells and covered in fresh culture medium.
Medium was refreshed three times per week for the duration of the
culture period.
Proliferative activity
Cell metabolic activity (n ¼ 5 smooth, n ¼ 5 etched) was evaluated
using Alamar BlueV (AB, Biorad). Scaffolds were first transferred
to new wells to measure the metabolic activity of adhered cells.
After 2, 14 and 21 days, cell culture medium containing 10% (v/v)
AB reagent was added to each well and the plates were incubated
for 5 h, after which 200 ml of each solution was transferred to
white opaque 96-well plates in triplicate. Absorbance was measured at 570/600 nm, using a microplate reader (Spectra Mac M3,
Molecular Devices). Percent reagent reduction was calculated
according to the manufacturer’s instructions by normalization to
the mean absorbance of blank controls (media with no cells) and
compared at each time point as an indirect measure of proliferative activity.
R

Cell morphology
At 21 days, smooth and etched PCL scaffolds were removed from
culture medium, washed in sterile PBS, and fixed with 3.7% formaldehyde in PBS for 10 min at room temperature. Subsequently, samples were washed with PBS again, and frozen before analysis. To
evaluate cell attachment and morphology, scaffolds (n ¼ 3 per
group) were immersed in 0.1% (v/v) Triton X-100 in PBS for 5 min
at room temperature, washed with PBS, stained with Alexa FluorV
647 (Invitrogen) according to the manufacturer’s instructions, and
counterstained with 0.5 mg/ml ethidium bromide. These particular
fluorescent markers were chosen because the PCL scaffolds do not
auto fluoresce at the excitation and emission maxima.
R

Immunofluorescent analysis of protein expression
Fixed and frozen scaffold samples were thawed and immersed in
0.3% (v/v) Triton X-100 for 5 min. Subsequently, non-specific binding was blocked by incubation at room temperature in 10% (v/v)
goat serum in 1 TBS. Scaffolds were incubated at room temperature for 1 h in mouse monoclonal antibody against bovine collagen
type I (COL1, Abcam, 1:100 dilution), collagen type II (COL2,
Abcam, 1:200 dilution), aggrecan (ACAN, Abcam, 1:50 dilution) or
rabbit anti-bovine polyclonal antibody against tenomodulin
(TNMD, Fisher Scientific, 1:100 dilution). Following three rinses in
1 TBS, scaffolds were treated with Alexa FluorV 647 secondary
antibodies (1:200 dilution of goat anti-mouse or goat anti-rabbit,
Abcam) for 30 min at room temperature. Staining without incubation of the primary antibody was conducted to ensure specificity of
the secondary antibody. Subsequently, all scaffolds were washed
three times in 1 TBS, counterstained with 0.5 mg/ml ethidium
R
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Figure 2. Morphological evaluation of the 3D printed PCL scaffolds. (a–c) Representative SEM images of scaffold A. (d) Increased spacing and decreased strut diameter resulted in increasing trends in porosity. The dashes show the median difference. Scale bars (a) 300 lm, (b) 500 lm, (c) 3000 lm.*Samples that were statistically significant, P < 0.05

Statistical analysis
Quantitative data sets were subjected to an analysis of variance and
unpaired two-sample t tests, assuming equal variance, with a post
hoc Bonferroni correction factor and statistical significance was set
at the 95% confidence interval (a =0.05).

Results
Scaffold morphological features
The 3D scaffolds were designed as shown in Fig. 1a and printed
with the size parameters shown in Fig. 1b. The morphology observed with SEM (Fig. 2a–c) revealed a homogenous porous structure and the ability of the design to mimic the angle-ply
architecture of the AF. Further SEM analysis revealed that the surface morphology of smooth and etched PCL did not change after
collagen coating (data not shown). The median measured porosities for scaffolds ‘A’ through ‘D’ ranged from 54 to 74%. Porosity
values increased with increased strut spacing and decreased strut
diameter (Fig. 2d).

Scaffold mechanical properties
Figure 3. Static mechanical properties of PCL scaffolds a through D. (a)
Unconfined compressive moduli measured in the axial direction. (b)
Circumferential tensile moduli. Mechanical properties increased with strut diameter and decreased strut spacing. The dashes show the median difference.
*Samples that were statistically significant, P < 0.05

bromide for 30 min at room temperature, and imaged using a confocal microscope (Model A1þ, Nikon Instruments Inc., Melville, NY,
USA) under 20 magnification. During image processing, cell nuclei
were modified to display in cyan for enhanced contrast.

The static mechanical properties of the scaffolds were evaluated at
room temperature under circumferential tension and axial compression. Overall, scaffolds with lower porosity exhibited higher mechanical properties. Median tensile moduli (Fig. 3a) ranged from
5.3 6 3.1 MPa (‘B’) to 18.0 6 3.1 MPa (‘C’). With strut spacing held
constant at 1200 lm, increasing strut diameter from 700 lm (‘A’) to
1300 lm (‘C’) resulted in a significant increase (P < 0.05) in tensile
modulus from 8.22 6 1.0 to 18.02 6 3.1 MPa. With strut diameter
held constant, decreasing the spacing from 2000 lm (‘C’) to
1300 lm (‘D’) resulted in a significant increase (P < 0.05) in tensile
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Figure 4. Single cantilever dynamic mechanical analysis was performed at a constant frequency of 1 Hz. Evolution of the storage modulus (E0 ), loss modulus (E00 ),
mechanical loss (tan d) and complex modulus (E*) with temperature was recorded. (a) Tg values did not vary significantly across the design matrix. (b) G0 values
at 25 C for scaffolds A–D showed the same trends as the static mechanical properties. The dashes show the median difference. (c, d) Mean values for E0 and E*
show that E0 is primarily governed by E* over the temperature range studied. *Samples that were statistically significant, P < 0.05

Table 1. Summary of the mechanical properties for each of the investigated PCL constructs as well as solid PCL
Sample

A
B
C
D
Solid

Strut diameter (mm)

Strut spacing (mm)

700
700
1300
1300

1300
2000
1300
2000

Porosity (%)

Molecular weight between
entanglements (Me) at 25 C (g/mol)

E0 at 25 C (MPa)

66.061.0
73.762.4
54.166.6
66.266.5

132.467.6
309.2681.1
72.461.2
137.063.3
19.060.4

60.365.1
27.267.7
106.363.3
62.4617.1
1678.44662.8

modulus from 9.92 6 1.8 to 18.02 6 3.1 MPa. The median compressive moduli (Fig. 3b) ranged from 0.31 6 0.2 MPa (‘B’) to
2.42 6 1.1 MPa (‘C’). Similarly to trends in tensile modulus, increasing strut diameter (‘A’ versus ‘C’) and decreasing strut spacing (‘C’
versus ‘D’) resulted in statistically significant increases in compressive moduli values (P < 0.05).
DMA analysis confirmed that Tg values for the scaffolds (Fig. 4a)
did not vary across the design matrix, an indication of the consistency of the printing conditions with respect to the molecular structure produced. The median values for storage moduli (E0 ) at 25 C,
reported in Fig. 4b, ranged from 31.59 6 7.7 to 105.60 6 3.3 MPa.
E0 is a quantitative measure of a material’s elasticity, or capability to
store energy and resist permanent deformation. Consistent with values for the static moduli, E0 values trended toward increasing with
decreasing strut spacing and increasing strut diameter. Increasing
strut diameter (‘A’ versus ‘C’) and decreasing strut spacing (‘C’ versus
‘D’) resulted in statistically significant increases in E0 values
(P < 0.05). This trend was consistent over the entire temperature
range studied (Fig. 4c). The complex modulus (E*, Fig. 4d) is a function of both the E0 and the loss modulus, E00 . E00 is a quantitative
measure of a material’s viscous behavior, or propensity to dissipate
energy. A comparison between E0 and E* (Fig. 4c and d) reveals that
the PCL scaffolds exhibited a significant elastic response, since the
values for E* are predominated by E0 [24]. Me is the measure of the

molecular weight of chain segments between nodes of the interacting polymer chains. Though Me characterizes microscopic polymer
interactions, the tested scaffolds contained varying macroscopic
gaps due to varying strut diameter and spacing. Consequently, although all were made of the same PCL material, the Me values of
the scaffolds differed from that of the solid PCL and from each
other. In general, scaffolds with smaller strut diameter, larger strut
spacing and high porosity exhibited higher Me and lower E0 .
Conversely, increased strut diameter, decreased strut spacing and
low porosity gave rise to lower Me and higher E0 . Therefore, larger
interstitial spaces led to weaker scaffold mechanical properties.
Summarized properties of scaffold architecture, porosity, molecular
weight between entanglements and storage modulus for each scaffold can be found in Table 1.

Scaffold biological properties
Due to its high mechanical properties, scaffold ‘C’ was chosen for
evaluation in the cell culture studies. The biological properties of
scaffold ‘C’ were investigated as a function of surface texture.
Directly after printing, scaffold ‘C’ exhibited a very smooth surface
(Fig. 5a). Manual etching by the unidirectional application of 30 lm
grit sandpaper across the PCL surface (back and forth several times)
successfully resulted in the formation of parallel grooves (Fig. 5b).
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Figure 5. SEM micrographs of scaffold C showing (a) smooth surface texture after printing and (b) unidirectional channels etched using 30 lm particle size sandV
paper. Bovine AF cells were cultured in vitro on both types of surfaces for 21 days, stained with Alexa Fluor 647 phalloidin (magenta) and counterstained with
ethidium bromide (nuclei are shown in cyan to enhance contrast). (c) Cells cultured on smooth PCL demonstrated random alignment. (d) Cells cultured on etched
PCL had a tendency to align along the underlying surface texture. (e) Alamar blue assay showed significant increases metabolic activity over the culture period,
confirming cell proliferation. Scale bars¼100 lm. *Statistical significance at single time point; #statistical significance compared with Day 2, P < 0.05
R

The size of the resulting topographical features ranged from 2 to
12 lm. As visualized by the cytoskeletal staining with phalloidin, bovine AF cells cultured on smooth surfaces exhibited attached,
spindle-like morphology and spread randomly across the surface by
Day 21 (Fig. 5c). In contrast, the culture of AF cells on etched surfaces exhibited a greater degree of alignment and a cytoskeletal arrangement coinciding with the underlying surface texture (Fig. 5d).

The metabolic activity of the cells over the 21-day culture period
was quantitated with an Alamar blue (AB) assay (Fig. 5e). Cells cultured on both types of surfaces exhibited statistically significant
increases in AB reagent reduction at Days 14 and 21 relative to Day 2
(P < 0.05), indicative of the PCL surfaces ability to support cell proliferation. At Days 14 and 21, AB reduction was significantly higher
(P < 0.05) for the cells cultures on etched versus smooth surfaces.
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Figure 6. Immunocytochemical results at Day 21 of culture for bovine AF cells seeded on smooth PCL surfaces. Scaffolds were treated with primary antibodies
V
targeting (a) ACAN, (b) COL 1, (c) COL 2, (d) TNMD. Alexa Fluor 647 was used for secondary antibody, and cells were counterstained with ethidium bromide.
Cell nuclei are shown in cyan to enhance contrast. Scale bars¼100 lm
R

Immunocytochemical staining was used to detect the presence or
absence of known IVD ECM components, COL1 (Fig. 6a), COL2
(Fig. 6b) and ACAN (Fig. 6c) [29–40]. Additionally, we evaluated
the presence of an AF-specific marker TNMD (Fig. 6d) [41].
Significant positive immunolabeling for COL1, ACAN and TNMD
for cells cultured on the PCL surfaces can be identified by the magenta color (Fig. 6). Minimal positive staining for COL2 was
detected. This result was expected, since the cells were extracted
from the outer AF tissue, which is predominantly Type I collagen
rather than Type II [42]. Immunocytochemical staining for the
etched surfaces detected the same strong positive expression of
COL1, ACAN and TNMD and weak expression of COL2.
Importantly, alignment of the proteins with the underlying surface
texture can be observed (Fig. 7).

Discussion
Current strategies for AF repair demonstrated modest success
in vivo, but do not completely restore the native structure and function to the degenerated IVD. Thus, there is a clinical need for new
solutions for AF regeneration. In this study, we describe the fabrication and characterization of 3D printed PCL scaffolds for AF tissue

engineering, which possess angle-ply architecture and exhibit several
promising properties for AF repair.
Biomechanical performance is critical for an AF repair device because it is necessary for withstanding in vivo stress concentrations,
mitigating or preventing further degeneration after implantation and
protecting seeded cells. The recommended tensile modulus for an AF
repair material is 11–29 MPa in the circumferential direction [43–45].
Scaffold ‘C’, with a median tensile modulus of 18 MPa, coincided with
this recommended range, while ‘A’, ‘B’ and ‘D’ were lower, but similar
in magnitude. Furthermore, the maximum tensile strain in the posterior AF was reported as 65% [46, 47]. All the tested PCL formulations
proved to be extremely ductile and far exceeded the strain level of
65% without failure (data not shown). Native AF compressive modulus has been reported to be 200 kPa [48]. All the scaffolds produced
for this study exceeded this mechanical requirement. Furthermore,
DMA analysis revealed appreciable elastic behavior for scaffolds ‘A’
through ‘D’, indicating the potential of the materials to resist permanent deformation with loading in the disc. More specifically, scaffold
‘C’ had the largest strut diameter and smallest spacing, thus resulting
in the lowest porosity, lowest Me and highest E0 . Scaffold architecture
must be considered when optimizing porosity and mechanical properties to allow for cell proliferation, aligned deposition of ECM and endurance of in vivo loading.
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Figure 7. Immunocytochemical results at Day 21 of culture for bovine AF cells seeded on smooth PCL surfaces. Scaffolds were treated with primary antibodies
V
targeting (a) ACAN, (b) COL 1, (c) COL 2, (d) TNMD. Alexa Fluor 647 was used for secondary antibody and cells were counterstained with ethidium bromide. Cell
nuclei are shown in cyan to enhance contrast. Scale bars¼100 lm
R

The fluorescence imaging and AB results confirm the biocompatibility of the PCL scaffolds and corroborate the results of other prior
studies demonstrating the promise of PCL in cellular tissue engineering [17, 18, 49–51]. Furthermore, confirmation of COL1, COL2,
ACAN and TNMD expression at the protein level demonstrated potential of the PCL to retain AF phenotype. However, a requisite for
engineering tissue that mimics the native AF is the deposition of
aligned matrix in an angle-ply configuration. Unidirectional surface
texture was incorporated onto the PCL struts, based on the hypothesis that the cells would align and deposit matrix along the surface
texture. Consistent with our hypothesis, the patterning of the surface induced cellular alignment and the subsequent deposition of
aligned proteins. In addition, the etched surfaces resulted in significantly higher AB reagent reduction compared with smooth surfaces
at Days 14 and 21. The increase is likely attributable to the increased surface area, allowing for greater cell level of cell proliferation. In this study, the grooves were generated with a range of sizes
by passing the sandpaper over the surface multiple times. Future
studies should examine the optimum size of the surface features.
PCL is widely known as a relatively stable polymer under hydrolytic degradation, requiring 2–4 years for complete degradation,
depending on the molecular weight [52] and morphology [53]. The
slow degradation rate makes it promising for the IVD, a loadbearing site with regenerative processes that take place over the
long-term [54–57]. Potentially, extrusion during printing can cause
degradation or chemical modifications to the PCL chains that

impact degradation behavior. In our case, strut diameter and overall
porosity can also affect scaffold degradation characteristics.
Domingos et al. [58] reported that the thermal extrusion process
had no effect on molecular weight (Mn), polydispersity index (Mw/
Mn) or crystalline fraction of the PCL. Dong et al. [59] studied the
degradation behavior of polyglycolide (PGA), poly(DL-lactide-coglycolide) (PLGA) and poly(L-lactide-co-e-caprolactone) [P(LLACL)] with and without cell culture. Cell culture significantly increased the degradation rate of PGA nanofibers, whereas the effect
on PLGA and P(LLA-CL) nanofibers was limited. Zhang et al. [60]
studied the mechanical characteristics of a 3D printed PCL scaffold
in an in vivo rabbit model. At 12 and 24 weeks post-implantation,
the tensile and compressive characteristics were higher for cellseeded scaffolds than cell-free, attributable to tissue deposition
within the scaffold by the cells. Prior to in vivo application of this
scaffold, in-depth study of the degradation rate as a function of morphology, printing parameters and cell growth will be required.
This is the first report in the literature with a 3D printed AF scaffold
that meets the requisite tensile and compressive mechanical requirements and promotes the directional deposition of tissue in an angle-ply
configuration. The concept has significant potential for a clinical impact. The 3D printing techniques, combined with clinical imaging, offer
the opportunity to create patient-specific implants for the IVD. While
the focus of this work is on developing a biomaterial that will advance
regeneration of AF tissue, in the long-term, the strategy can be integrated into a 3D printing approach to whole-disc replacement.

In vitro evaluation of 3D printed polycaprolactone scaffolds
There are some limitations with the current study. While the current scaffold captures the angle-ply configuration of the disc, it does
not capture the heterogeneity of the native tissue. For instance, the
stiffness of AF tissue significantly varies depending on the location.
The outer AF, rich in Collagen I, is stiffer than the inner AF, which
has higher levels of aggrecan and Collagen II [42, 61].
Correspondingly, the AF phenotype transitions from fibroblast-like
in the outer annulus to chondrocyte-like in the inner annulus [62,
63]. Fortunately, 3D printing is a versatile method that allows for
modification of the biomaterial design to incorporate site-specific
biochemical cues and mechanical gradients, substantially advancing
AF scaffold design. Furthermore, an in-depth biomechanical characterization of the scaffolds is needed, to capture its performance under torsion and fatigue conditions. In terms of scaffold biological
performance, engineered tissue should be quantified in terms of proteogylcan and collagen content, as well as ratio of Collagen I and II.
Additional AF markers should be evaluated at a gene and protein
level. These can include cartilage oligomatrix matrix protein [38],
glypican 3 [64], integrin-binding sialoprotein [29], and fibulin 1
[65], Collagen V [66], CD146þ [67]. Lastly, adipose and bone derived MSCs have been demonstrated to have potential in AF repair
[11, 68]. MSCs can be obtained with less morbidity than somatic
cell types [69] and thus have more clinical significance, and should
be evaluated in further studies.

Conclusions
Multi-layer scaffolds were 3D printed by depositing PCL struts in
opposing angular orientations of 630 , replicating the angle-ply arrangement of the native AF tissue. Scaffolds were printed with strut
diameters of 700 or 1300 lm and parallel spacing between the struts
of 1300 or 2000 lm. The scaffolds exhibited significant elastic
responses. The circumferential tensile moduli were of similar magnitude to native AF tissue. The axial compressive properties exceeded
what has been reported for native tissue. The scaffold with 1300 lm
strut diameter and spacing supported the attachment and proliferation of bovine AF cells, as well as the expression of Collagen I,
aggrecan and tenomodulin by the cells. The etching of the scaffold
with unidirectional surface texture induced cellular alignment and
the deposition of the protein markers along the underlying surface
texture. The results of these in vitro studies demonstrate the potential for using this novel scaffold in IVD repair.
Conflict of interest statement. None declared.
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